EPITHELIAL P2X PURINERGIC RECEPTOR CHANNELS
EPITHELIAL P2X PURINERGIC RECEPTOR CHANNELS
批准号:
6629054
负责人:
Erik Mills Schwiebert
金额:
$20.14万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-05 至 2005-01-31
关键词:
RNase protection assay adenosine triphosphate calcium channel calcium flux calcium indicator chloride channels cystic fibrosis disease /disorder model genetically modified animals laboratory mouse messenger RNA northern blottings nucleic acid sequence polymerase chain reaction potassium channel protein isoforms purinergic receptor receptor expression respiratory epithelium sodium channel voltage /patch clamp
中文摘要
囊性纤维化(CF)的气道上皮细胞有许多缺陷,包括氯离子(Cl-)和液体转运的丧失,粘液纤毛清除的丧失,顶端自分泌和旁分泌的ATP信号的丧失,以及Na+转运的增加。外源性核苷酸激动剂恢复细胞外APT信号并刺激囊性纤维化(CF)气道上皮细胞的氯离子和液体运输。因此,雾化核苷酸激动剂疗法已被提出用于治疗慢性阻塞性肺疾病。为了了解核苷酸激动剂如何调节CF和非CF的气道上皮功能,需要对质膜嘌呤能受体有完整的了解。我们实验室的初步数据显示,一类新的嘌呤能受体--P2X受体通道(P2XRs)由呼吸道上皮细胞表达。P2XR在上皮细胞中的表达和功能的细胞和分子生理学研究尚未见报道。P2XRs是一种配体门控通道,它在胞外区域与ATP结合,在质膜上形成内源性的钙离子通道,具有非选择性。ATP门控的P2XRs可能通过调节细胞外钙内流或触发钙依赖的蛋白激酶信号来影响上皮细胞的功能。因此,我们将检验这一中心假设:P2X嘌呤能受体通道由呼吸道上皮细胞表达,并作为ATP门控的钙离子内流通道,调节氯离子、钠离子和液体通过呼吸道上皮细胞的运输。由于对呼吸道上皮细胞中的P2XRs知之甚少,我们预计将会发现新的和令人兴奋的结果。由于我们的初步数据显示,在CF和非CF的呼吸道上皮细胞中,P2XR的表达相似,而且信标酶P2XR激动剂在体外和体内都能刺激CF和非CF的小鼠和人的呼吸道上皮分泌Cl-,因此,激活P2XR可能提供一种新的途径,通过它来恢复正常的CI-、Na+和液体通过CF呼吸道的运输,并改善CF肺的粘液纤毛清除。
英文摘要
Cystic fibrosis (CF) airway epithelia have many defects including a loss in chloride (Cl-) and fluid transport, a loss in mucociliary clearance, a loss in apical autocrine and paracrine ATP signaling, and a gain in Na+ transport. Exogenous nucleotide agonists restore extracellular APT signaling and stimulate Cl- and fluid transport in cystic fibrosis (CF) airway epithelia. As such, aerosolized nucleotide agonist therapy has been proposed to treat CF airways. To understand how nucleotide agonists regulate CF and non-CF airway epithelial function, a complete understanding of plasma membrane purinergic receptors is required. Preliminary data from our laboratory reveal that a new class of purinergic receptor, the P2X receptor channels (P2XRs), are expressed by airway epithelia. The cellular and molecular physiology of P2XR expression and function has not been studied in epithelia. P2XRs are ligand-gated channels that bind ATP in an extracellular domain and form intrinsic calcium (Ca2+)- permeable, non-selective cation channels in the plasma membrane. ATP-gated P2XRs may affect epithelial cell function by mediating influx of Ca2+ from extracellular stores or by triggering Ca2+- dependent protein kinase signaling. Therefore, we will test the central hypothesis that: P2X purinergic receptor channels are expressed by airway epithelia and function as ATP-gated Ca2+ influx channels to regulate Cl-, Na+, and fluid transport across airway epithelia. Because little is known about P2XRs in airway epithelia, we anticipate that new and exciting results will be found. Because our preliminary data demonstrate that P2XR expression is similar in CF versus non-CF airway epithelia and beacuase P2XR agonists stimulate Cl- secretion across both CF and non-CF mouse and human airway epithelium in vitro and in vivo, activation of P2XRs may provide a novel approach with which to restore normal Cl-, Na+, and fluid transport across CF airways and improve mucociliary clearance from CF lungs.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Transient transfection of polarized epithelial monolayers with CFTR and reporter genes using efficacious lipids.
使用有效脂质瞬时转染带有 CFTR 和报告基因的极化上皮单层。
DOI:
10.1152/ajpcell.00435.2002
发表时间:
2003
期刊:
American journal of physiology. Cell physiology
影响因子:
--
作者:
[Tucker,TorryA, Varga,Karoly, Bebok,Zsuzsa, Zsembery,Akos, McCarty,NaelA, Collawn,JamesF, Schwiebert,ErikM, Schwiebert,LisaM]
通讯作者:
Schwiebert,LisaM
DOI:
10.1152/ajpcell.00491.2004
发表时间:
2005-08
期刊:
American journal of physiology. Cell physiology
影响因子:
--
作者:
[L. Liang;Á. Zsembery;E. Schwiebert]
通讯作者:
L. Liang;Á. Zsembery;E. Schwiebert
Large pore formation uniquely associated with P2X7 purinergic receptor channels. Focus on "Are second messengers crucial for opening the pore associated with P2X7 receptor?".
大孔的形成与 P2X7 嘌呤能受体通道独特相关。
DOI:
10.1152/ajpcell.00532.2004
发表时间:
2005
期刊:
American journal of physiology. Cell physiology
影响因子:
--
作者:
[Liang,Lihua, Schwiebert,ErikM]
通讯作者:
Schwiebert,ErikM
DOI:
10.1152/ajpcell.2000.279.2.c281
发表时间:
2000-08
期刊:
American journal of physiology. Cell physiology
影响因子:
--
作者:
[E. Schwiebert]
通讯作者:
E. Schwiebert
DOI:
10.1016/j.jcf.2004.01.006
发表时间:
2004-06-01
期刊:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
影响因子:
--
作者:
[Braunstein, Gavin M, Zsembery, Akos, Schwiebert, Erik M]
通讯作者:
Schwiebert, Erik M
Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia
-
批准号:9139596
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2016
-
负责人:Erik Mills Schwiebert
-
依托单位:
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease
-
批准号:8454042
-
项目类别:
-
资助金额:$43.66万
-
财政年份:2013
-
负责人:Erik Mills Schwiebert
-
依托单位:
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease
-
批准号:8803107
-
项目类别:
-
资助金额:$50.34万
-
财政年份:2013
-
负责人:Erik Mills Schwiebert
-
依托单位:
DBM Anti-Proliferative Lead Small Molecules for Polycystic Kidney Disease
-
批准号:8892174
-
项目类别:
-
资助金额:$63.17万
-
财政年份:2013
-
负责人:Erik Mills Schwiebert
-
依托单位:
Discovery of Inhibitors of PTH-Wnt Signaling Synergy in Bone Cells
-
批准号:8000306
-
项目类别:
-
资助金额:$23.43万
-
财政年份:2010
-
负责人:Erik Mills Schwiebert
-
依托单位:
Discovery of Novel Anti-Inflammatory Phytochemicals on Human Cell Platforms
-
批准号:7926261
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2010
-
负责人:Erik Mills Schwiebert
-
依托单位:
CF Corrector Ligands Discovered on CF Human Airway Cells
-
批准号:8200582
-
项目类别:
-
资助金额:$72.62万
-
财政年份:2009
-
负责人:Erik Mills Schwiebert
-
依托单位:
Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis
-
批准号:7853245
-
项目类别:
-
资助金额:$1.55万
-
财政年份:2009
-
负责人:Erik Mills Schwiebert
-
依托单位:
Cystic Fibrosis Corrector Ligands Discovered in CF Human Airway Cells
-
批准号:7748575
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2009
-
负责人:Erik Mills Schwiebert
-
依托单位:
CF Corrector Ligands Discovered on CF Human Airway Cells
-
批准号:8330822
-
项目类别:
-
资助金额:$65.14万
-
财政年份:2009
-
负责人:Erik Mills Schwiebert
-
依托单位:
Sodium Transport Inhibitors for Hypertension and Cystic Fibrosis
-
批准号:7612426
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2008
-
负责人:Erik Mills Schwiebert
-
依托单位:
Ion Transport Dysregulation in Cilium-deficient ARPKD
-
批准号:6989180
-
项目类别:
-
资助金额:$27.59万
-
财政年份:2005
-
负责人:Erik Mills Schwiebert
-
依托单位:
Ion Transport Dysregulation in Cilium-deficient ARPKD
-
批准号:7108698
-
项目类别:
-
资助金额:$26.21万
-
财政年份:2005
-
负责人:Erik Mills Schwiebert
-
依托单位:
EXTRACELLAR NUCLEOTIDE SIGNALING IN CYSTIC FIBROSIS
-
批准号:6476260
-
项目类别:
-
资助金额:$16.44万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
EXTRACELLAR NUCLEOTIDE SIGNALING IN CYSTIC FIBROSIS
-
批准号:6624922
-
项目类别:
-
资助金额:$16.94万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
EPITHELIAL P2X PURINERGIC RECEPTOR CHANNELS
-
批准号:6033315
-
项目类别:
-
资助金额:$21.2万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
EPITHELIAL P2X PURINERGIC RECEPTOR CHANNELS
-
批准号:6351601
-
项目类别:
-
资助金额:$18.98万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
EXTRACELLAR NUCLEOTIDE SIGNALING IN CYSTIC FIBROSIS
-
批准号:6329424
-
项目类别:
-
资助金额:$15.96万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
EXTRACELLAR NUCLEOTIDE SIGNALING IN CYSTIC FIBROSIS
-
批准号:6683657
-
项目类别:
-
资助金额:$17.44万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
EXTRACELLAR NUCLEOTIDE SIGNALING IN CYSTIC FIBROSIS
-
批准号:6044885
-
项目类别:
-
资助金额:$18.77万
-
财政年份:2000
-
负责人:Erik Mills Schwiebert
-
依托单位:
海外基金